ClinicalTrials.gg
RecruitingNCT05889559Updated Nov 12, 2026

Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Syndrome (ACS)

An interventional study of Tissue Ultrafiltration Catheters in Acute Compartment Syndrome, Fracture, Bone and Tibial Fractures, sponsored by Major Extremity Trauma Research Consortium. Recruiting at 4 sites in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Primary conditionTibial FracturesRegistry: Fractures, BoneReclassifiedWhy we changed it
Registry
Fractures, Bone — the first condition term the registry derived for this study.
ClinicalTrials.gg
Tibial Fractures
Why
  1. The study's listed conditions name Tibial Fractures, a narrower term within Fractures, Bone.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Major Extremity Trauma Research Consortium · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.
Updated Nov 12, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.

Planned enrollment
18th of 38
60 · median 53
Started
2024
with 3 others
No phase
27 of 50
10 open now
Primary completion
2027-06
later than 10 of 17 live
Registered
42nd of 50
by date
Lead sponsor
3 of 50
Major Extremity Trauma Research Consortium

Among the 50 studies in Tibial Fractures with a site in United States, this one is the 18th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2024, is one of 27 with no phase, reaches primary completion later than 10 of the 17 other live ones, and was the 42nd registered.

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

Browse Tibial Fractures studies →

Open to participants now

15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Tibial Fractures with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if tissue ultrafiltration (TUF) catheters can reduce intramuscular pressure and prevent acute compartment syndrome (ACS) in adults ages 18-60 with severe proximal tibia or tibial shaft fractures.

The main questions it aims to answer are:

Will intramuscular pressure (IMP) be lower in the TUF cohort compared to controls?

Will the consensus likelihood of ACS, incidence of fasciotomy, and 6-month functional outcomes be better in the TUF cohort?

Are interstitial fluid biomarkers predictive of ACS?

Researchers will compare patients randomized to TUF catheters (n=30) versus control patients receiving standard-of-care only (n=30) to see if TUF lowers ACS risk and improves recovery.

Participants will:

Be enrolled within 14 hours of injury or prior to high-risk surgery within 48 hours.

Receive continuous anterior compartment pressure monitoring.

Undergo standard-of-care clinical evaluation and treatment.

(TUF arm only) Have three TUF catheters placed in the injured limb to remove interstitial fluid.

Return for a 6-month follow-up to assess complications, healing, muscle function, and patient-reported outcomes.

(Hennepin Healthcare subset) Provide interstitial fluid samples for biomarker analysis.

Read the detailed description

The study will enroll 60 adults ages 18-60 admitted to the hospital with severe open or closed fractures of the proximal tibia or tibial shaft at risk for ACS. Participants will be randomized to either treatment with tissue ultrafiltration (TUF) catheters (n=30) or to a control group (n=30). Patients will be enrolled within 14 hours of initial injury, or just prior to undergoing surgical procedures that are associated with a risk of post-operative ACS within 48 hours of injury. All patients will receive continuous pressure monitoring of the anterior compartment of their leg. Both groups will receive comprehensive clinical evaluation and will be treated according to the standard-of-care regarding management of their underlying injury and diagnosis of ACS as practiced by their treating surgeon. In addition, patients randomized to the experimental arm will have three TUF catheters placed in the anterior muscle compartment of the injured limb. The TUF catheters will be connected to a closed suction drain and will remove interstitial fluid from the muscle. All patients will be followed at 6 months following initial hospital discharge. This visit will include a clinical evaluation of complications, hospital admission and emergency room visits, wound and fracture healing, infection, muscle sensory and function exam and patient-reported outcome.

We hypothesize that intramuscular pressure (IMP) will be lower in the TUF cohort compared to controls. In addition, we expect that the expert panel consensus likelihood of ACS, defined as the median of the ratings of the individual panel members who evaluated each patient, and the incidence of fasciotomy will be lower in the TUF cohort. Finally, patients in the TUF cohort will demonstrate superior functional outcome at 6 months following injury compared to those in the control cohort, levels of specific biomarkers as measured in the interstitial fluid will be worse in patients with ACS compared to patients without ACS in the treatment group, and there will be a threshold for each biomarker which is predictive of ACS (biomarkers will be collected from at least 10 patients/ up to full sample of intervention arm patients enrolled at Hennepin Healthcare only).

03

Conditions studied

  • Acute Compartment Syndrome
  • Fracture, Bone
  • Tibial Fractures

Browse trials for

04

In context

Tibial Fractures Reclassified

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

This study's planned enrollment of 60 is close to the median of 66 across 92 interventional studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Major Extremity Trauma Research Consortium is the lead sponsor of 31 studies on the registry; 5 are open to participants now.

Compared within Tibial Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Fractures, Bone. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

INCLUSION CRITERIA The target population for this study include adults ages 18-60 with high-energy injuries of the upper leg considered at risk for ACS at time of admission by virtue of their mechanism of injury, fracture pattern, clinical signs, or need to undergo fracture fixation surgery (internal or external fixation) within 48 hours of admission. Recruitment of participants will happen during hospital admission for treatment of injury.

Eligible patients must meet all of the following criteria and be enrolled during one of two possible times: within 14 hours of injury, or prior to undergoing surgical intervention (internal or external fixation on the injured limb) within 48 hours of admission. Eligible patients will be:

  1. Between the ages of 18 and 60 years
  2. Have sustained a high-energy upper leg injury such as open or closed proximal tibial shaft fracture with displacement, comminution, or segmental pattern; proximal fibula fracture; bicondylar tibial plateau fracture; Schatzker IV medial knee fracture-dislocation; proximal leg injury due to shotgun, rifle, or other projectile, or severe crushing injury.
  3. Patient can be enrolled in the study and study procedures initiated within 14 hours of injury,* or be enrolled prior to undergoing urgent surgical intervention on the injured limb (defined as internal or external fixation) within 48 hours of admission.
  4. Patient (or authorized legal representative) willing to sign .

    • If a patient has an eligible injury and is going to surgery within 2 hours (except for fasciotomy - which is an exclusion criteria), the patient can be enrolled and the study procedures initiated at the end of surgery. If an eligible patient is enrolled and there is no surgery anticipated within 2 hours, initiate study procedures immediately.

EXCLUSION CRITERIA

An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Patients not willing to participate
  2. Patients with non-traumatic cases of acute compartment syndrome (e.g. severe exertion, snakebite, high-pressure injection injury)
  3. Patients diagnosed with ACS or impending ACS such that immediate fasciotomy is recommended
  4. Soft tissue wounds, including lacerations or abrasions, that are in a location that will interfere with safe insertion of indwelling pressure or TUF catheters (anterior - anterolateral aspect of the leg)
  5. Patients not likely to follow-up (are homeless, incarcerated, live out-of-state).
  6. Patients with known peripheral vascular disease
  7. Non-ambulatory due to an associated complete spinal cord injury; Non-ambulatory before the injury due to a pre-existing condition.
  8. Very low clinical concern for ACS at time of admission.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control Pressure Monitoring Group

    Participants in this group will have pressure monitoring of the anterior compartment of their leg using an indwelling IMP catheter (MY01, MY01 Inc., Montreal, CA). The participants will be treated according to the standard-of-care regarding management of their underlying injury and diagnosis of ACS as practiced by their treating surgeon. Participants will be followed for six months post-injury.

  • Experimental
    Tissue Ultrafiltration Intervention Group (TUF)

    Participants in this group will have pressure monitoring of the anterior compartment of their leg using an indwelling IMP catheter (MY01, MY01 Inc., Montreal, CA). The participants will be treated according to the standard-of-care regarding management of their underlying injury and diagnosis of ACS as practiced by their treating surgeon. In addition, participants in this group will will undergo three TUF of the anterior compartment of the injured limb. Participants will be followed for six months post-injury.

    Device: Tissue Ultrafiltration Catheters

Interventions

  • DeviceTissue Ultrafiltration Catheters

    patients randomized to the experimental arm will have three TUF catheters placed in the anterior muscle compartment of the injured limb. The TUF catheters will be connected to a closed suction drain and will remove interstitial fluid from the muscle.

07

What researchers measure

Primary outcomes

  1. To test whether TUF reduces Intramuscular Pressure (IMP) compared to control patients.

    Proportion of patients with a of Change in continuously measured IMP.

    Time frame: 6 months post injury

Secondary outcomes

  1. To test whether there are differences in the incidence of ACS in patients with severe leg injuries treated with active TUF compared to the control group.

    The consensus likelihood of ACS as assessed by a panel of experts after review of a standardized patient profile.

    Time frame: 6 months post injury

  2. To test whether TUF reduces the incidence of fasciotomy compared to control patients.

    Proportion of patients with a fasciotomy.

    Time frame: 6 months post injury

  3. To test the impact of TUF on improving patient Global Health

    Veteran Rand 12 Health Survey (VR12)

    Time frame: 6 months post injury

  4. To test the impact of TUF on improving patient physical function

    PROMIS Physical Function

    Time frame: 6 months post injury

08

Study locations

4 of 4 sites recruiting
  • University of Maryland School of Medicine R Adams Cowley Shock Trauma Center
    Baltimore, Maryland 21201, United States
    Recruiting
  • Hennepin Healthcare Research Institute
    Minneapolis, Minnesota 55415-1623, United States
    Recruiting
  • Atrium Health Musculoskeletal Institute
    Charlotte, North Carolina 28207, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
    Recruiting
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jun 2027, 41 months after the start.

Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 41 months is close to that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Jan 2026 → Jun 2027 and completion Jul 2026 → Jul 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2023
First posted
Jun 5, 2023
StartActual
Jan 1, 2024
Primary completionEst.
Jun 1, 2027was Jan 2026
CompletionEst.
Jul 1, 2028was Jul 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 1, 2026→Jun 1, 2027
Nov 12, 2026
Study completion
Jul 1, 2026→Jul 1, 2028
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Jan 1, 2026→Jun 1, 2027
    Study completion Jul 1, 2026→Jul 1, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05889559
Lead sponsor
Major Extremity Trauma Research Consortium
Responsible party
Sponsor
First posted
Jun 5, 2023
Start date
Jan 1, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Jul 1, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Dana Alkhoury, MPH
Contact
dalkhou1@jhu.edu
(410) 955-7498

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion